Seers Technology

KQ:458870 Korea Medical Devices
Market Cap
$1.44 Billion
₩2.11 Trillion KRW
Market Cap Rank
#7557 Global
#162 in Korea
Share Price
₩166400.00
Change (1 day)
-1.77%
52-Week Range
₩11330.00 - ₩172200.00
All Time High
₩172200.00
About

Seers Technology Co., LTD. provides telemedicine solutions with patient monitoring in South Korea. It offers wearable biosensor, central patient monitoring system, medical AI, and medical adhesive material. The company was founded in 2009 and is headquartered in Pyeongtaek-si, South Korea.

Seers Technology (458870) - Net Assets

Latest net assets as of March 2025: ₩20.96 Billion KRW

Based on the latest financial reports, Seers Technology (458870) has net assets worth ₩20.96 Billion KRW as of March 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩27.97 Billion) and total liabilities (₩7.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩20.96 Billion
% of Total Assets 74.91%
Annual Growth Rate 9.0%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 109.44

Seers Technology - Net Assets Trend (2022–2024)

This chart illustrates how Seers Technology's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Seers Technology (2022–2024)

The table below shows the annual net assets of Seers Technology from 2022 to 2024.

Year Net Assets Change
2024-12-31 ₩21.40 Billion +163.91%
2023-12-31 ₩8.11 Billion -54.97%
2022-12-31 ₩18.01 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Seers Technology's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1920616597000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock ₩6.28 Billion 29.33%
Other Components ₩60.32 Billion 281.87%
Total Equity ₩21.40 Billion 100.00%

Seers Technology Competitors by Market Cap

The table below lists competitors of Seers Technology ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Seers Technology's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 8,108,486,580 to 21,398,870,840, a change of 13,290,384,260 (163.9%).
  • Net loss of 8,871,453,220 reduced equity.
  • Share repurchases of 22,486,289,680 reduced equity.
  • Other factors increased equity by 44,648,127,160.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩-8.87 Billion -41.46%
Share Repurchases ₩22.49 Billion -105.08%
Other Changes ₩44.65 Billion +208.65%
Total Change ₩- 163.91%

Book Value vs Market Value Analysis

This analysis compares Seers Technology's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 97.60x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 113.60x to 97.60x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2022-12-31 ₩1464.82 ₩166400.00 x
2023-12-31 ₩659.55 ₩166400.00 x
2024-12-31 ₩1704.86 ₩166400.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Seers Technology utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -41.46%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -109.53%
  • • Asset Turnover: 0.29x
  • • Equity Multiplier: 1.31x
  • Recent ROE (-41.46%) is above the historical average (-69.37%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2022 -44.36% -692.86% 0.05x 1.18x ₩-9.79 Billion
2023 -122.30% -526.10% 0.11x 2.11x ₩-10.73 Billion
2024 -41.46% -109.53% 0.29x 1.31x ₩-11.01 Billion

Industry Comparison

This section compares Seers Technology's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $98,321,642,752
  • Average return on equity (ROE) among peers: 7.10%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Seers Technology (458870) ₩20.96 Billion -44.36% 0.33x $944.23 Million
Shinhung (004080) $87.31 Billion 3.50% 0.52x $10.80 Million
Osang Healthcare Co.,Ltd (036220) $199.86 Billion 20.34% 0.25x $37.44 Million
HansBiomed Corporation (042520) $43.16 Billion 11.38% 0.21x $246.58 Million
JVM Co. Ltd (054950) $98.83 Billion 10.23% 0.72x $117.37 Million
Huvitz Co. Ltd (065510) $51.68 Billion 16.97% 0.32x $43.64 Million
Vieworks Co. Ltd (100120) $188.04 Billion 17.80% 0.28x $101.54 Million
Corentec Co Ltd (104540) $48.30 Billion -3.04% 0.46x $40.80 Million
Hironic Co. Ltd (149980) $40.72 Billion 7.13% 0.15x $23.71 Million
Laseroptek Co., Ltd. (199550) $-3.94 Billion 0.00% 0.00x $21.68 Million
Humasis Co. Ltd (205470) $229.26 Billion -13.28% 0.45x $48.97 Million